Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
64 Cards in this Set
- Front
- Back
myocardial contractility
|
the force of contraction
-exercise increases contractility -sleeping/resting decreases contractility |
|
cardiac output
|
the volume of blood expelled by the ventricles of the heart every minute
average=5L/min |
|
cardiac output=
|
heart rate X stroke volume
|
|
stroke volume
|
the volume of blood expelled in one heart beat
-strong contraction= increased SV -weak contraction= decreased SV |
|
3 factors that influence stroke volume
|
1) myocardial contractility: force of contraction
2) after-load: load against which a muscle exerts its force 3) pre-load: amount of tension/stretch applied to muscle PRIOR to contraction |
|
after load
|
the resistance against which a muscle exerts its force and the muscle must overcome to contract
|
|
heart rate
|
heart beats per minute
|
|
preload
|
amount of tension/stretch applied to a muscle PRIOR to contraction
|
|
starling's theory
|
the bigger the muscle, the bigger the stretch PRIOR to contraction
|
|
vasoconstriction will __________________ afterload
|
INCREASE
|
|
as after load increases, stroke volume _____________
|
DECREASES
|
|
as preload increases, stroke volume _________________
|
INCREASES
|
|
arterial pressure=
|
cardiac output X peripheral resistance
|
|
physiologic regulators of blood pressure (3)
|
sympathetic nervous system, RAAS system, kidneys
|
|
sympathetic nervous system causes what changes (5)
|
-blood pressure increase
-heart rate increase -epinephrine and norepineprine are released and cause increased contractility -bronchodilation -vasoconstriction of unimportant vessels--that blood gets pushed to muscles and organs needed for fight or flight response |
|
RAAS system (5)
|
1-release of renin
2-conversion of angiotensin 1 3-conversion to angiotensin 2 via ACE enzyme 4-causes systemic vasoconstriction 5-causes secretion of aldosterone |
|
what does aldosterone do?
|
makes kidneys retain sodium and water
|
|
when does the RAAS system kick in?
|
whenever there is decreased perfusion of the kidneys; dehydration or stress
|
|
#1 cause of heart failure
|
uncontrolled HYPERtension
|
|
cardiac output is determined by (4)
|
-heart rate
-contractility -blood volume -venous return |
|
pulse rate is determined by
|
arteriolar constriction
|
|
classes of drugs that REDUCE AFTERLOAD
|
-beta adrenergic blockers
-calcium channel blockers -vasodilators -ACE inhibitors -angiontensin II receptor blockers |
|
beta blockers
MOA |
block beta 1 receptors in cardiac muscle which LOWERS cardiac contractility and LOWERS blood pressure
DIRECT IMPACT ON SYMPATHETIC NERVOUS SYSTEM |
|
beta blockers
USES |
-arrhythmias
-angina -HYPERtension -post MI -early stages of heart failure -migraines -stage fright *athletes can use BB to promote coordination |
|
beta blockers
SIDE EFFECTS |
CARDIAC:
-bradycardia (HR<60) -fatigue -HYPOtension -dizziness PULMONARY: -bronchoconstriction -bronchospasm ENDOCRINE: -MASK symptoms of hypoglycemia -can CAUSE hypoglycemia *****AVOID FOR ASTHMA/COPD PATIENTS****** NEUROLOGICAL: -fatigue/malaise -sexual dysfunction *depression |
|
who SHOULDNT take beta blockers?
|
diabetics, because glycogenolysis is mediated by beta receptors
ASTHMA/COPD PATIENTS |
|
ending of most beta blockers
|
-OLOL
|
|
generations of beta blockers (3)
|
FIRST:
non-selective block b1 and b2 receptors (propranOLOL) SECOND: cardio-selective produce selective blockade of b1 receptors (metoprOLOL & atenOLOL) THIRD: vasodilating which act on blood vessels to cause dilation, but may produce nonselective or cardioselective beta blockade (carvediLOL) |
|
beta blockers
DRUG INTERACTIONS |
-any drug that lowers blood pressure- risk of HYPOtension
-calcium channel blockers + BB= bradycardia -insulin+BB= hypoglycemia |
|
calcium channel blockers
MOA |
agents that act mainly on vascular smooth muscle
-significantly blocks calcium channels and cause VASODILATION= lowers blood pressure |
|
calcium channel blockers: family
dihydropyridine DRUGS AND MOA |
DRUGS: amlodipine & nifedipine (ENDS IN -PINE)
agents that act on vascular smooth muscle by causing VASODILATION |
|
calcium channel blockers: family
dihydropyridine SIDE EFFECTS |
-HYPOtension
***-REFLEX TACHYCARDIA -flushing -headache -dizziness -peripheral EDEMA |
|
calcium channel blockers: family
dihydropyridine DRUG INTERACTIONS |
-any drug that lowers BP= HYPOtensin
-CCB+BB= control reflex tachycardia (can add diuretic if edema is present) -CCB+DIURETIC= control edema |
|
calcium channel blockers: other 2 drugs
DRUG NAMES AND MOA |
DRUGS: verapamil & diltiazem
MOA: agents that act on vascular smooth AND the heart [VASODILATION] (affinity to cardiac muscle) contractility DECREASES, heart rate DECREASES BLOCK CALCIUM CHANNELS IN VSM AND HEART |
|
calcium channel blockers: verapamil & diltiazem
USES |
-angina
-anti arrhythmias |
|
calcium channel blockers: verapamil & diltiazem
SIDE EFFECTS |
-HYPOtension
**-bradycardia -flushing -headache -dizziness -constipation -peripheral edema |
|
calcium channel blockers: verapamil & diltiazem
DRUG INTERACTIONS |
-any drug that lowers BP= risk of HYPOtension
-BB+ V/D= extensive drop in heart rate ****-digoxin+verapamil= risk for digoxin toxicity |
|
vasodilators: DIRECT ACTING
MOA |
relax vascular smooth muscle and cause VASODILATION
**REDUCE CARDIAC WORKLOAD** |
|
vasodilators: DIRECT ACTING
SIDE EFFECTS |
-orthostatic HYPOtension
-reflex tachycardia= increases workload (BAD) -increase blood volume and edema/ fluid retention= activate RAAS system **WHEN GIVEN ALONE EXPECT TO SEE REFLEX TACHYCARDIA** |
|
vasodilators: DIRECT ACTING
DRUG INTERACTIONS |
-any drug that lowers BP= risk of HYPOtension
-vasodilators+BB= reduce/block reflex tachycardia -vasodilators+diuretic=reduce edema |
|
drugs acting on the RAAS system
|
ACE inhibitors & angiotensin II receptor blockers
|
|
physiological action of angiotensin II
|
-systemic vasoconstriction= INCREASES BP (to push blood out of kidneys)
-makes body secrete aldosterone (retention of NA and water)= INCREASED blood volume, INCREASED blood pressure |
|
why do we block RAAS?
|
to DECREASE blood pressure and DECREASE fluid retention
|
|
ACE inhibitors
MOA & COMMON ENDING |
inhibiting/blocking ACE enzyme causing a reduction in angiotensin II
**inhibiting ACE results in VASODILATION (reduce blood volume/sodium retention/water retention)** ENDS IN -opril (lisinopril) |
|
ACE inhibitors
USES |
-HYPERtension
-heart failure- because they reduce after load to give heart a 'rest' -post MI- reduce mortality after MI -decrease proteinuria and slow development of nephropathy in diabetic patients |
|
ACE inhibitors
SIDE EFFECTS |
1) HYPOtension
2) COUGH**** 3) HYPERkalemia 4) fetal injury 5) angioedema ------------ -decrease vascular/cardiac remodeling [GOOD] |
|
ACE inhibitors
DRUG INTERACTIONS |
-any drug that lowers BP= risk of HYPOtension
-any drug that raises K= HYPERkalemia -diuretics= FIRST DOSE HYPOTENSION |
|
cardiac remodeling
|
the process where ventricles dilate (MORE CONTRACTILITY), hypertrophy (WALL THICKNESS INCREASES), and become more spherical
BAD |
|
ACE inhibitors effect on heart
|
PREVENT or REVERSE remodeling in cardiac muscle and blood vessel walls in heart disease
|
|
ACE inhibitors effect on kidneys
|
DECREASE proteinuria and slow development of kidney disease/failure in DIABETICS
|
|
angiotensin II receptor blockers
MOA AND COMMON ENDING |
DIRECTLY block angiotensin II receptors which results in blocking the effects of angiotensin II= VASODILATION and DECREASE in sodium and water retention
ENDS IN -sartan (losartan) |
|
angiotensin II receptor blockers (ARBs)
USES |
-HYPERtension
-heart failure -post MI -reduce kidney problems |
|
angiotensin II receptor blockers
SIDE EFFECTS |
-HYPOtension
-fetal injury -angioedema (RARE) |
|
angiotensin II receptor blockers
DRUG INTERACTIONS |
-ACE inhibitors+ARBs= SHOULD NOT BE USED TOGETHER
-any drug that lowers BP= risk of HYPOtension |
|
cardiac glycosides: digoxin
MOA |
INCREASE force of contractility by inhibiting enzyme SODIUM POTASSIUM ATPase
-when you inhibit this you promote calcium to accumulate inside the cell= increases contractile force [cardiac output increases] **VERY NARROW THERAPEUTIC INDEX** |
|
cardiac glycosides: digoxin
SIDE EFFECTS/SIGNS OF TOXICITY |
GI:
-nauseous -vomiting -anorexia CARDIAC: -cause arrhythmias (check APICAL pulse BEFORE you give digoxin to assess for abnormalities) CNS: -visual changes (blurred vision, 'halos') -mental status change (delirium/confusion) ANTIDOTE: -digoxin immune fab 'digibind' |
|
stages of heart failure (4)
|
A: at high risk for heart failure but WITHOUT structural heart disease or symptoms of heart failure
-GIVE ACE INHIBITOR B: structural heart disease but WITHOUT symptoms of heart failure -ACE INHIBITOR= reduce remodeling; BETA BLOCKER= reduce SNS C: structural heart disease WITH prior or current symptoms of heart failure -DIURETIC; ACE INHIBITOR; BETA BLOCKER D: ADVANCED structural heart disease with marked symptoms of heart failure AT REST and requiring special interventions -DO NOT GIVE BETA BLOCKER |
|
heart failure is characterized by:
|
-ventricular dysfunction
-REDUCED cardiac output -signs of fluid retention -INCREASED heart rate -INCREASED contractility |
|
cardiac contractility is affected by:
|
-stress
-activity -anxiety -heart failure |
|
drugs used to treat heart failure
#1 |
DIURETICS:
-1st line drugs for patients with signs of volume overload -REDUCES BLOOD VOLUME -does not prolong survival/symptom control |
|
drugs used to treat heart failure
#2 |
AGENTS INHIBITING RAAS
--------- ACE INHIBITORS: -improve functional status -prolong life -improve hemodynamics and alter cardiac remodeling ------ ARBs |
|
drugs used to treat heart failure
#3 |
BETA-BLOCKERS:
-can improve patient status -need to be controlled carefully -protects heart from excessive sympathetic stimulation -PROTECTS AGAINST DYSRHYTHMIAS |
|
drugs used to treat heart failure
#4 |
DIGOXIN:
-positive inotropic agent (impacts contractility, increases force of contraction, increases workload) -improves muscle contraction |
|
Nursing responsibilities
|
-monitor digoxin levels
-monitor potassium levels -check apical pulse for one minute to assess for abnormalities -assess 'halos' if present |